Daily Archives: September 2, 2020


In 2019, the FDA approved esketamine, a derivative of ketamine, for treatment of severe depression when oral anti-depressants alone are unsuccessful.  Ketamine is sometimes thought to be a controversial treatment because despite being used for years in the hospital setting as an anesthetic and painkiller, it is also frequently abused as a recreational club drug.   … Read More